Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 86.34
+1.04 (1.22%)
Nov 13, 2026, 3:00 PM CST
SHA:688016 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,455 | 1,351 | 1,206 | 1,187 | 896.5 | 684.63 |
Revenue Growth | 16.24% | 11.96% | 1.61% | 32.43% | 30.95% | 45.59% |
Gross Profit Gross Profit Growth | 1,063 | 950.79 | 876.06 | 901.27 | 671.76 | 530.63 |
Operating Income Operating Income Growth | 625.6 | 584.69 | 522.21 | 534.36 | 373.27 | 317.95 |
Net Income Net Income Growth | 582.84 | 563.33 | 502.1 | 492.43 | 356.88 | 315.86 |
Earnings Per Share EPS Growth | 4.82 | 4.65 | 4.07 | 4.57 | 3.33 | 2.95 |
EPS Growth | 55.43% | 14.25% | -10.95% | 37.30% | 12.99% | 47.32% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 1,094 |
Overseas Overseas Growth | 256.95 |
Total Total Growth | 1,350 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,080 | 2,103 | 2,171 | 2,967 | 976.89 | 1,243 |
Total Debt Total Debt Growth | 14.03 | 14.98 | 40.86 | 35.75 | 41.18 | 45.81 |
Net Cash (Debt) Net Cash Growth | 2,066 | 2,088 | 2,130 | 2,931 | 935.71 | 1,197 |
Net Cash Growth | -2.76% | -1.96% | -27.34% | 213.26% | -21.86% | 13.90% |
Net Cash Per Share Net Cash Per Share Growth | 17.08 | 17.24 | 17.26 | 27.21 | 8.73 | 11.17 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 481.39 | 573.06 | 373.6 | 558.31 | 333.76 | 300.25 |
Capital Expenditures CapEx Growth | -249.18 | -303.03 | -212.65 | -190.26 | -293.98 | -89.58 |
Free Cash Flow Free Cash Flow Growth | 232.21 | 270.03 | 160.95 | 368.05 | 39.78 | 210.67 |
Free Cash Flow Growth | 307.80% | 67.77% | -56.27% | 825.13% | -81.12% | 10.17% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.10% | 70.40% | 72.62% | 75.91% | 74.93% | 77.51% |
Operating Margin | 43.00% | 43.29% | 43.29% | 45.01% | 41.64% | 46.44% |
Pretax Margin | 46.28% | 48.38% | 54.06% | 48.20% | 46.17% | 52.83% |
Profit Margin | 40.06% | 41.71% | 41.62% | 41.48% | 39.81% | 46.13% |
FCF Margin | 15.96% | 19.99% | 13.34% | 31.00% | 4.44% | 30.77% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.300 | 2.300 | 2.012 | 2.013 | 1.544 | 1.409 |
Dividend Per Share Growth | 39.39% | 14.31% | -0.07% | 30.44% | 9.52% | 133.34% |
Dividend Yield | 2.66% | 2.51% | 1.83% | 1.54% | 1.22% | 0.84% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.91 | 19.67 | 26.77 | 32.70 | 38.13 | 56.68 |
Forward PE | 16.60 | 16.89 | 17.88 | 23.59 | 26.68 | 46.41 |
P/FCF Ratio | 44.93 | 41.04 | 83.52 | 43.75 | 342.02 | 84.98 |
PS Ratio | 7.17 | 8.21 | 11.14 | 13.56 | 15.18 | 26.15 |